Articles

Poll

Podcasts

Slideshows

Videos

Patients hospitalized for severe COVID-19 had an accelerated eGFR decline relative to those with pneumonia due to other infections.

COVID-19 Infection Linked to Faster Kidney Function Decline Than Pneumonia

To celebrate the close of 2024, we're recapping the 10 most popular approval articles across the HCPLive Network of brands.

HCPLive Year in Review: Top 10 FDA Approvals for 2024

From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.

HCPLive Year in Review: Top Podcasts & Shows for 2024

Gestational exposure to certain NSAIDs during different trimesters of pregnancy was associated with an increased risk of childhood CKD.

Use of Ibuprofen, Other NSAIDs During Pregnancy Could Increase Risk of Childhood CKD

The FDA's decision not to approve sotagliflozin as an adjunct in T1D and CKD comes less than 2 months after a negative advisory committee meeting for the application. 

FDA Issues CRL for Sotagliflozin in Type 1 Diabetes and CKD

Yehuda Handelsman, MD highlights insulin resistance’s role in cardiometabolic disease and introduces DCRM 2.0 as a global, multi-specialty care framework.

Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0

Study findings suggest the potential utility of ΔADC for assisting the clinical, pathological, and prognostic risk stratification of patients with IgAN.

Delta Corticomedullary Apparent Diffusion Coefficient Aids IgAN Risk Stratification

Matthew Weir, MD discusses how a multidisciplinary approach is reshaping CKD management, with a focus on mitigating cardiovascular events.

Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease

Despite having a lower risk of hospitalization, cardiovascular events, and mortality, patients with IgAN and FSGS had a higher risk of CKD progression.

IgAN, FSGS Linked to Greater Kidney Replacement Therapy Risk Than Common CKD Etiologies

In the final segment of this episode, the discussion focuses on next steps for the PARASOL Initiative and its potential to transform FSGS drug development.

Kidney Compass: Future of PARASOL and FSGS Management

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Nephrology